E80.29
Other porphyria
Clinical Classification Guidelines
Inclusion Terms
- Hereditary coproporphyria
Medical Intelligence & Overview
Hereditary coproporphyria (HCP) is a rare genetic disorder that affects the production of heme, an essential component of hemoglobin in your blood. Classified under ICD-10 code E80.29 as 'Other porphyria,' it arises due to a deficiency of specific enzymes involved in heme synthesis. This condition can cause a variety of symptoms, primarily affecting the skin and nervous system, with episodes that may be triggered by certain environmental factors or illnesses. Understanding the causes, symptoms, and management options can help in controlling and monitoring this condition effectively.
Causes & Symptoms
Clinical Causes: Inherited genetic mutation affecting the coproporphyrinogen oxidase enzyme Autosomal dominant inheritance pattern, meaning only one copy of the mutated gene is sufficient to cause the disorder Possible environmental triggers such as alcohol, certain medications, fasting, or infections that can precipitate symptoms
Key Symptoms: Abdominal pain and discomfort Psychological disturbances like anxiety, depression, or confusion Skin issues including sensitivity to sunlight, leading to blisters or rashes Muscle weakness or neurological symptoms such as tingling or numbness Dark-colored urine, especially after exposure to sunlight or during episodes Fluctuating episodes of symptoms that can last from hours to weeks
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory tests. Tests such as urine porphyrin analysis can detect excess porphyrins characteristic of HCP. Blood and stool tests may also be conducted to assess enzyme activity and confirm the genetic mutation. Genetic testing can identify the specific mutation responsible for the disorder, supporting diagnosis and familial screening.
Treatment Protocols: Management of hereditary coproporphyria focuses on preventing and controlling symptoms. Approaches include avoiding known triggers like certain medications, alcohol, and fasting. During acute attacks, hospitalization may be necessary for intravenous heme therapy and supportive care. Long-term management involves regular monitoring and genetic counseling. Some patients may benefit from medications that suppress heme precursor production or mitigate symptoms, under medical supervision.
Clinical Advice & FAQs
Billing Guidance
Is E80.29 a billable ICD-10 code?
Yes, E80.29 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E80.29?
Clinical documentation must specify the nature of Other porphyria and any associated comorbidities for accurate reporting.
Cite this Clinical Reference